SOBR Safe, Inc. (SOBR)
USD 0.9
(-10.0%)
USD 0.9
(-10.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 157.29 Thousand | 35.32 Thousand | - | - | - | - |
| Cost of Revenue | 94.94 Thousand | 19.31 Thousand | 385.46 Thousand | 232.19 Thousand | - | - |
| Gross Profit | 62.35 Thousand | 16 Thousand | -385.46 Thousand | -232.19 Thousand | - | - |
| Operating Expenses | 9.66 Million | 10.42 Million | 5.55 Million | 2.9 Million | 787.29 Thousand | 298.95 Thousand |
| Selling, General and Administrative Expenses | 8.64 Million | 9.03 Million | 4.35 Million | 2.27 Million | 787.29 Thousand | 298.95 Thousand |
| Research and Development Expenses | 1.4 Million | 1.39 Million | 1.19 Million | 633.05 Thousand | 12.78 Thousand | 8855.00 |
| Other Expenses | - | 230.41 Thousand | 473.74 Thousand | 1.64 Million | - | - |
| Cost and Expenses | 9.75 Million | 10.44 Million | 5.55 Million | 2.9 Million | 787.29 Thousand | 298.95 Thousand |
| Operating Income | -9.6 Million | -10.41 Million | -5.55 Million | -2.9 Million | -787.29 Thousand | -298.95 Thousand |
| Interest Expense | 804.26 Thousand | 3.45 Million | 2.25 Million | 1.54 Million | 469.01 Thousand | 263.17 Thousand |
| Income Tax Expense | - | 8.5 Million | 2.25 Million | 1.54 Million | 465.88 Thousand | -3158.00 |
| Earnings before Tax | -10.21 Million | -12.35 Million | -7.87 Million | -29.98 Million | -1.25 Million | -562.12 Thousand |
| Net Income | -10.21 Million | -20.85 Million | -10.12 Million | -31.53 Million | -1.71 Million | -558.96 Thousand |
| Earnings Per Share Basic | -61.91 | -1.90 | -1.17 | -6.14 | -1.01 | -0.49 |
| Earnings Per Share Diluted | -61.91 | -1.90 | -1.17 | -6.14 | -1.01 | -0.49 |
| Weighted Average Shares Outstanding | 164.98 Thousand | 11 Million | 8.65 Million | 5.13 Million | 1.69 Million | 1.14 Million |
| Weighted Average Shares Outstanding (Diluted) | 164.98 Thousand | 11 Million | 8.65 Million | 5.13 Million | 1.69 Million | 1.14 Million |
| Gross Margin | 0.40 | 0.45 | - | - | - | - |
| EBIT Margin | -58.59 | -277.38 | - | - | - | - |
| Profit Margin | -64.94 | -590.46 | - | - | - | - |
| EBITDA | -9.21 Million | -8.51 Million | -5.16 Million | -28.2 Million | 4150.00 | -298.95 Thousand |
| Earnings Before Tax Margin | -61.04 | -294.81 | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 54.19 Thousand | 47.99 Thousand | 35.54 Thousand | 157.29 Thousand | 36.27 Thousand | 37.6 Thousand |
| Cost of Revenue | 137.52 Thousand | 121.14 Thousand | 124.47 Thousand | 480.4 Thousand | 20.19 Thousand | 16.57 Thousand |
| Gross Profit | -83.33 Thousand | -73.15 Thousand | -88.92 Thousand | -323.11 Thousand | 16.07 Thousand | 21.02 Thousand |
| Operating Expenses | 1.79 Million | 1.63 Million | 2.29 Million | 9.27 Million | 2.08 Million | 2.72 Million |
| Selling, General and Administrative Expenses | 1.48 Million | 1.53 Million | 1.87 Million | - | 1.86 Million | 2.52 Million |
| Research and Development Expenses | 308.42 Thousand | 102.03 Thousand | 427.83 Thousand | - | 214.37 Thousand | 193.17 Thousand |
| Other Expenses | 13.15 Thousand | -564.62 Thousand | 1.59 Million | 2.15 Million | 48.67 Thousand | 60.58 Thousand |
| Cost and Expenses | 1.93 Million | 1.75 Million | 2.42 Million | 9.75 Million | 2.1 Million | 2.73 Million |
| Operating Income | -1.87 Million | -1.7 Million | -2.38 Million | -9.6 Million | -2.06 Million | -2.69 Million |
| Interest Expense | 213.29 Thousand | 232.51 Thousand | 190.93 Thousand | -804.26 Thousand | 179.01 Thousand | 209.12 Thousand |
| Income Tax Expense | 345.62 Thousand | 1.52 Million | -4.00 | -17.00 | -4.00 | -4.00 |
| Earnings before Tax | -2.07 Million | -2.5 Million | -2.54 Million | -10.21 Million | -2.19 Million | -2.87 Million |
| Net Income | -2.07 Million | -2.5 Million | -2.54 Million | -10.21 Million | -2.19 Million | -2.87 Million |
| Earnings Per Share Basic | -0.09 | -0.13 | -0.14 | - | -0.12 | -0.16 |
| Earnings Per Share Diluted | -0.09 | -0.13 | -0.14 | - | -0.12 | -0.16 |
| Weighted Average Shares Outstanding | 23.42 Million | 19.07 Million | 18.56 Million | 18.14 Million | 18.54 Million | 18.36 Million |
| Weighted Average Shares Outstanding (Diluted) | 23.42 Million | 19.07 Million | 18.56 Million | 18.14 Million | 18.54 Million | 18.36 Million |
| Gross Margin | -1.54 | -1.52 | -2.50 | -2.05 | 0.44 | 0.56 |
| EBIT Margin | -32.86 | -33.60 | -64.44 | - | -52.99 | -67.61 |
| Profit Margin | -38.33 | -52.22 | -71.50 | -64.94 | -60.58 | -76.43 |
| EBITDA | -1.78 Million | -1.61 Million | -2.29 Million | - | -1.92 Million | -2.54 Million |
| Earnings Before Tax Margin | -34.64 | -35.61 | -67.15 | -61.04 | -56.98 | -71.79 |
FDA
ESCORP
5512
S24
EDRVF
CAAOF